A SIMPLE KEY FOR CHLORPROMAZINE UNVEILED

Antibodies are classified as the primary course of therapeutics, owing largely to their capacity to interact with unique ligand conformations so as to elicit individual biological responses. However, discovery of new molecules binding unique epitopes is time intensive and demanding, especially for scenarios requiring a selected antibody-ligand orie